Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study

Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study

Marjaana Koponen,1– 3 Anne Paakinaho,1,2 Julian Lin,1,2 Sirpa Hartikainen,1,2 Anna-Maija Tolppanen1,2 1School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland; 2Kuopio Research Centre of Geriatric Care, University of Eastern Finland, Kuopio, Finland; 3Center fo...

Full description

Bibliographic Details
Main Authors: Koponen M, Paakinaho A, Lin J, Hartikainen S, Tolppanen AM
Format: Article
Language:English
Published: Dove Medical Press 2022-10-01
Series:Clinical Epidemiology
Subjects:
parkinson’s disease
pharmacoepidemiology
drug repurposing
case-control study
indication bias
Online Access:https://www.dovepress.com/identification-of-drugs-associated-with-lower-risk-of-parkinsons-disea-peer-reviewed-fulltext-article-CLEP

Internet

https://www.dovepress.com/identification-of-drugs-associated-with-lower-risk-of-parkinsons-disea-peer-reviewed-fulltext-article-CLEP

Similar Items